Comera Life Sciences Holdings, Inc.: Nasdaq/NYSE listing notice — Comera receives Nasdaq delisting notice; expects to trade on OTC Markets

Comera Life Sciences Holdings, Inc.

On Oct 31, 2023, Comera notified by Nasdaq of failure to cure $1.00 minimum bid price deficiency within 180-day period; not eligible for second period.
Hearings panel to consider this deficiency; Company must submit written views by Nov 7, 2023.
Previously, Nasdaq granted conditional continued listing until Nov 14, 2023, subject to meeting bid price and MVLS rules.
Company believes it is unlikely to regain compliance by Nov 14; expects delisting and trading on OTC Markets.
If delisted, Comera will remain an SEC reporting company under Exchange Act.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Comera Life Sciences Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A), 5550(b)(2)

Exact text from the filing

October 31, 2023, Comera Life Sciences Holdings, Inc. (the “Company”) received notice from The Nasdaq Stock Market LLC that the Company had not regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (the “bid price requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) within the 180 calendar day period provided by Rule 5810(c)(3)(A) and that the Company is not eligible for a second 180 day period to regain compliance. The notice letter indicated that the Nasdaq Hearings Panel will consider this matter in their decision regard

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.85

Comera Life Sciences Holdings, Inc. received a nasdaq hearing update notice regarding market value (rules 5550(b)(2), 5550(a)(2), 5550(b)).

Exchange: nasdaq
Notice: hearing update
Deficiency: market value
Rules: 5550(b)(2), 5550(a)(2), 5550(b)

Exact text from the filing

”) received notice from The Nasdaq Stock Market LLC that the Company had not regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (the “bid price requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) within the 180 calendar day period provided by Rule 5810(c)(3)(A) and that the Company is not eligible for a second 180 day period to regain compliance.

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-23-058855

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.